(Q34648041)

3 August 2017

title

Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study (English)

1 reference

post-traumatic stress disorder

3 August 2017

main subject

0 references

author name string

Won-Myong Bahk

1

1 reference

3 August 2017

Chi-Un Pae

2

1 reference

3 August 2017

Joshua Tsoh

3

1 reference

3 August 2017

Jeong-Ho Chae

4

1 reference

3 August 2017

Tae-Youn Jun

5

1 reference

3 August 2017

Chul-Lee

6

1 reference

3 August 2017

Kwang-Soo Kim

7

1 reference

3 August 2017

publication date

1 October 2002

1 reference

3 August 2017

published in

Human Psychopharmacology

1 reference

3 August 2017

volume

17

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

341-344

1 reference

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

3 August 2017

cites work

1 reference

SPRINT: a brief global assessment of post-traumatic stress disorder

21 January 2018

1 reference

Treatment for posttraumatic stress disorder

21 January 2018

1 reference

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

21 January 2018

1 reference

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites

21 January 2018

1 reference

SSRI and mirtazapine in PTSD.

21 January 2018

1 reference

Posttraumatic stress disorder in the National Comorbidity Survey

21 January 2018

1 reference

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

21 January 2018

1 reference

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

A pilot study of mirtazapine in post-traumatic stress disorder

21 January 2018

1 reference

7 January 2021

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

7 January 2021

Structured interview for PTSD (SIP): psychometric validation for DSM-IV criteria

1 reference

7 January 2021

Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics

1 reference

7 January 2021

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

1 reference

7 January 2021

Nefazodone in post-traumatic stress disorder: results from six open-label trials

1 reference

7 January 2021

Comorbidity, Impairment, and Suicidality in Subthreshold PTSD

1 reference

7 January 2021

Mirtazapine: pharmacology in relation to adverse effects

1 reference

7 January 2021

Alprazolam reduces response to loud tones in panic disorder but not in posttraumatic stress disorder

1 reference

7 January 2021

Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.426

1 reference

3 August 2017

1 reference